Diasorin
Generated by Meeveem AI
"World leaders in laboratory diagnostics, specialists in immunodiagnostics and molecular solutions"
Saluggia, Italy
•1000+ Employees
•Diagnostics
About Diasorin
DiaSorin develops diagnostic solutions for clinical laboratories worldwide. The company specialises in immunodiagnostics and molecular diagnostics, producing tests that detect antibodies, antigens, and pathogens in biological samples. Their platforms serve clinicians in infectious disease, oncology, endocrinology, and other critical care areas. Operating across 26 countries and serving over 100 markets, DiaSorin combines rigorous science with entrepreneurial agility. Public since 2007 and part of the FTSE MIB index, the company continues to expand through innovation and strategic acquisition, most notably its 2021 purchase of Luminex Corporation.
4429
Team Members
1968
Founded
Diagnostics
Sector
Hybrid
Work Environment
Our Vision
A world where diagnostic science empowers rapid, accurate healthcare decisions, improving patient outcomes across every community and clinical setting globally
Our Mission
Diasorin is dedicated to the relentless pursuit of scientific discovery that improves lives every single day by empowering healthcare providers with actionable information to drive excellence in patient care